Your browser doesn't support javascript.
loading
Short- and Long-Term Incidence of Thromboembolic Events in Takotsubo Syndrome as Compared With Acute Coronary Syndrome.
El-Battrawy, Ibrahim; Gietzen, Thorsten; Lang, Siegfried; Ansari, Uzair; Behnes, Michael; Zhou, Xiaobo; Borggrefe, Martin; Akin, Ibrahim.
Afiliação
  • El-Battrawy I; 1 First Department of Medicine, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany.
  • Gietzen T; 2 DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Mannheim, Germany.
  • Lang S; 1 First Department of Medicine, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany.
  • Ansari U; 2 DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Mannheim, Germany.
  • Behnes M; 1 First Department of Medicine, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany.
  • Zhou X; 2 DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Mannheim, Germany.
  • Borggrefe M; 1 First Department of Medicine, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany.
  • Akin I; 1 First Department of Medicine, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany.
Angiology ; 70(9): 838-843, 2019 Oct.
Article em En | MEDLINE | ID: mdl-30987433
ABSTRACT
Thromboembolic events are a common complication in Takotsubo syndrome (TTS). However, their long-term incidence compared with acute coronary syndrome (ACS) is lacking. In-hospital and long-term incidence of thromboembolic events of 138 consecutive patients with TTS were compared with 138 sex- and age-matched patients with ACS. Predictors of events were analyzed. The incidence of thromboembolic events in TTS was 2-fold higher than ACS (21% vs 9%; P < .01) over a mean follow-up of 5 years. Although the left ventricular ejection fraction (LVEF) at event was significantly lower in TTS compared with ACS (38% [9%] vs 54% [11%]; P < .01), the follow-up LVEF was comparable. Patients with TTS suffering from thromboembolic events were more often treated with anticoagulation compared with ACS (44.8% vs 8.3%, P = .03). However, more patients presenting with ACS (100% vs 48.3%; P < .01) were discharged on aspirin. Only elevated C-reactive protein was a predictor of thromboembolic events using multivariate analysis (hazard ratio 1.1, 95% confidence interval, 1.0-1.2; P < .01). In conclusion, the risk of thromboembolic events in TTS was significantly higher than the risk of thromboembolic events in ACS over a mean follow-up of 5 years.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia / Função Ventricular Esquerda / Síndrome Coronariana Aguda / Cardiomiopatia de Takotsubo Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Angiology Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia / Função Ventricular Esquerda / Síndrome Coronariana Aguda / Cardiomiopatia de Takotsubo Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Angiology Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha